scispace - formally typeset
Open AccessJournal ArticleDOI

p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c-Kit activity.

TLDR
High levels of p130Cas, via abnormal c‐Kit activation, promote mammary luminal cell plasticity, thus providing the conditions for the development of basal‐like breast cancer.
Abstract
It has recently been proposed that defective differentiation of mammary luminal progenitors predisposes to basal-like breast cancer. However, the molecular and cellular mechanisms involved are still unclear. Here, we describe that the adaptor protein p130Cas is a crucial regulator of mouse mammary epithelial cell (MMEC) differentiation. Using a transgenic mouse model, we show that forced p130Cas overexpression in the luminal progenitor cell compartment results in the expansion of luminal cells, which aberrantly display basal cell features and reduced differentiation in response to lactogenic stimuli. Interestingly, MMECs overexpressing p130Cas exhibit hyperactivation of the tyrosine kinase receptor c-Kit. In addition, we demonstrate that the constitutive c-Kit activation alone mimics p130Cas overexpression, whereas c-Kit downregulation is sufficient to re-establish proper differentiation of p130Cas overexpressing cells. Overall, our data indicate that high levels of p130Cas, via abnormal c-Kit activation, promote mammary luminal cell plasticity, thus providing the conditions for the development of basal-like breast cancer. Consistently, p130Cas is overexpressed in human triple-negative breast cancer, further suggesting that p130Cas upregulation may be a priming event for the onset of basal-like breast cancer.

read more

Citations
More filters
Journal ArticleDOI

p130Cas/BCAR1 scaffold protein in tissue homeostasis and pathogenesis.

TL;DR: More recent data on the contribution of p130Cas/BCAR1 in the regulation of tissue homeostasis and its potential implications in pathological conditions are discussed.
Journal ArticleDOI

Cas proteins: dodgy scaffolding in breast cancer

TL;DR: Two Cas proteins are focused on, p130Cas/BCAR1 and Nedd9, and their coupled signalling pathways, to examine their role in mammary cell transformation and in the acquirement of invasiveness and drug resistance of breast cancer cells.
Journal ArticleDOI

Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

TL;DR: It is shown that BCAR3-induced antiestrogen resistance in MCF7 breast cancer cells critically depends on its ability to bind BCAR1, and strategies to disruptBCAR1-BCAR3/NSP3 complexes and associated signaling networks could ultimately lead to new breast cancer therapies.
Journal ArticleDOI

Essential role of SH3GL1 in interleukin-6(IL-6)- and vascular endothelial growth factor (VEGF)-triggered p130 cas -mediated proliferation and migration of osteosarcoma cells

En-qi Li, +1 more
- 12 Jul 2017 - 
TL;DR: The results strongly suggest that SH3GL1 is a novel target for anti-osteosarcoma.
Journal ArticleDOI

Identification of afzelin potential targets in inhibiting triple-negative breast cancer cell migration using reverse docking.

TL;DR: Afzelin was predicted to inhibit TNBC cell motility, by targeting ERK2, KRas, and FAK activation and played a dominant role in forming hydrogen bonds with the target proteins.
References
More filters
Journal ArticleDOI

Hallmarks of 'BRCAness' in sporadic cancers

TL;DR: There are properties that define 'BRCAness' — that is, traits that some sporadic cancers share with those occurring in either BRCA1- or BRCa2-mutation carriers, which might have important implications for the clinical management of these cancers.
Journal ArticleDOI

Purification and unique properties of mammary epithelial stem cells

TL;DR: The use of multi-parameter cell sorting and limiting dilution transplant analysis is reported to demonstrate the purification of a rare subset of adult mouse mammary cells that are able individually to regenerate an entire mammary gland within 6 weeks in vivo while simultaneously executing up to ten symmetrical self-renewal divisions.
Journal ArticleDOI

Cells of origin in cancer

TL;DR: Evidence is also accumulating that cancers of distinct subtypes within an organ may derive from different 'cells of origin', and the identification of these crucial target cell populations may allow earlier detection of malignancies and better prediction of tumour behaviour.
Related Papers (5)